BIO.B (STOCKS)
Bio-Rad Laboratories, Inc. Class B
$295.050000
+0.000000 (+0.00%)
Prev close: $295.050000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Norman D. Schwartz
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $7,958.93M
- Employees
- 7,700
- P/E (TTM)
- -12.14
- P/B (TTM)
- 1.18
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
4
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$2.26 | $1.95 | +0.3074 | +15.74% |
|
Jun 2025 (Q2)
|
$2.61 | $1.75 | +0.8592 | +49.07% |
|
Mar 2025 (Q1)
|
$2.54 | $1.83 | +0.7122 | +38.96% |
|
Dec 2024 (Q4)
|
$2.90 | $2.90 | +0.0028 | +0.10% |
Financial Statements
| Assets | $10.21B |
| Current Assets | $2.81B |
| Inventory | $798.80M |
| Prepaid Expenses | $149.60M |
| Other Current Assets | $1.86B |
| Noncurrent Assets | $7.40B |
| Intangible Assets | $396.90M |
| Other Non-current Assets | $7.01B |
| Liabilities | $3.09B |
| Current Liabilities | $548.90M |
| Accounts Payable | $139.30M |
| Wages | $157.80M |
| Other Current Liabilities | $251.80M |
| Noncurrent Liabilities | $2.54B |
| Equity | $7.13B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $7.13B |
| Liabilities And Equity | $10.21B |